- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: factor VIII
Total 30083 results
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia AUnited States, France, Italy, Spain, Netherlands, United Kingdom, Ireland, New Zealand, Poland, Australia, Germany, Brazil, Sweden, Canada
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, United Kingdom, Australia
-
Spanish Society of Thrombosis and HaemostasisTakeda; Instituto de Investigación Hospital Universitario La PazCompletedHemophilia A | Hemophilia | Factor VIII DeficiencySpain
-
Green Cross CorporationAtlantic Research GroupUnknownHemophilia AUnited States, Canada, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia B | Hemophilia A or B With InhibitorsPoland, United States, Bulgaria, Romania, Japan, Russian Federation, New Zealand, Croatia, Ukraine, Brazil
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Taiwan, Poland, Bulgaria, United Kingdom, Germany, Turkey, Israel, Malaysia, Ukraine, Russian Federation, Austria, Switzerland, Japan, Hong Kong, Lithuania, Roman... and more
-
Hampshire Hospitals NHS Foundation TrustUppsala University; University of Wales Cardiff United Kingdom (UK)CompletedSevere Haemophilia AUnited Kingdom
-
St. James's Hospital, IrelandBaxter BioScienceUnknownSevere Haemophilia AIreland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Spain, Germany, Switzerland, Macedonia, The Former Yugoslav Republic of, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Israel, Russian Federation, Turkey, Lithuania, Poland, Japan, Latvia, Puerto...
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Baxalta now part of ShireCompletedHemophilia ACzechia, Bulgaria, Hungary, Poland
-
Novo Nordisk A/SEnrolling by invitationCongenital Bleeding Disorder | Congenital FXIII DeficiencyJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Macedonia, The Former Yugoslav Republic of, Serbia, Malaysia, Brazil, Turkey, Lithuania, Russian Federation, Italy, Japan, Poland, Puerto Rico, Taiwan
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia AUnited States, New Zealand, Australia, Hungary, Sweden, Austria, Poland, Romania
-
BayerCompletedHemophilia AKorea, Republic of, Taiwan, Turkey, Singapore, United States, Netherlands, Austria, Denmark, United Kingdom, Belgium, Italy, France, Japan, Germany, Israel, Poland, Canada, Norway, Romania, Colombia
-
Wyeth is now a wholly owned subsidiary of PfizerTerminated
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AChina
-
PfizerCompleted
-
BayerCompleted
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.Active, not recruitingHemophilia ASpain, United States, Denmark, Italy, Taiwan, Malaysia, Belgium, Thailand, Turkey, Austria, Bulgaria, Canada, Finland, France, Germany, Hong Kong, Hungary, Korea, Republic of, Netherlands, Norway, Singapore, Ukraine, United Kingdom
-
Bioverativ Therapeutics Inc.CompletedHemophilia AUnited States, Canada, Italy, Australia, Austria, Belgium, Brazil, France, Germany, Hong Kong, India, Ireland, Israel, Japan, Netherlands, New Zealand, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Medical University of GrazActive, not recruiting
-
Aljazeera HospitalCompleted
-
BayerActive, not recruiting
-
Baxalta now part of ShireCompletedHemophilia AUnited States, France, Austria, United Kingdom, Germany, Belgium, Canada, Italy, Sweden
-
Swedish Orphan BiovitrumICON plcCompletedHemophilia AFrance, Italy, Norway, Sweden, United Kingdom, Austria, Belgium, Finland, Spain
-
United States Army Institute of Surgical ResearchCompleted
-
Beijing 302 HospitalRecruiting
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Canada, Puerto Rico
-
Beijing Children's HospitalUnknownHemophilia A With InhibitorChina
-
The League of Clinical Research, RussiaCompletedHemophilia ARussian Federation
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Spain, Switzerland, Taiwan, Turkey, United Kingdom, Croatia, Germany, Brazil, France, Japan, Australia, Hungary, Israel, Korea, Republic of, Lithuania, Portugal, Ukraine, Greece, Italy, Denmark, Norway, Canada and more
-
BayerCompletedHemophilia ABelgium, New Zealand, Netherlands, Greece, United Kingdom, Austria, United States, Italy, Romania, Bulgaria, Canada, Israel, Poland, Lithuania, Norway, Argentina, Spain
-
BayerCompletedHemophilia ASwitzerland, France, Spain, Sweden, Austria, Italy, Belgium, Denmark, Greece, Netherlands
-
University of AarhusCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerWithdrawnHemophilia AItaly, United States, Netherlands, United Kingdom, Germany, New Zealand, Belgium, France
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia ASpain, Germany, Malaysia, Latvia
-
BayerCompletedHemophilia A | Hematologic DiseaseFrance, Italy, Spain, United States, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Poland, Slovenia, Greece, Russian Federation, Hungary, Italy, United Kingdom, Czechia, Austria
-
Oregon Health and Science UniversityBaxter Healthcare CorporationCompleted
-
BayerCompletedHemophilia A, CongenitalSlovenia, Italy, Germany, France, United States, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencySpain, United States, Canada, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom, Israel, United States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom
-
BayerTerminatedHemophilia AUnited States